<![CDATA[Janssen's Updated Phase 1 Results for Teclistamab in MM]]>Janssen's Updated Phase 1 Results for Teclistamab Suggest Deep, Durable Responses in Patients with Heavily Pretreated Multiple Myeloma

Link Preview Image
Janssen's Updated Phase 1 Results for Teclistamab Suggest Deep, Durable Responses in Patients with Heavily Pretreated Multiple Myeloma

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today longer follow-up results from the Phase 1 MajesTEC-1 study, the...

favicon

(www.prnewswire.com)

]]>https://dev.proinvestor.com/forum/topic/442708/janssens-updated-phase-1-results-for-teclistamab-in-mmRSS for NodeMon, 06 Jul 2026 23:42:53 GMTMon, 24 May 2021 10:46:57 GMT60